AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,761 | +25.5% | 1,839 | -7.8% | 0.00% | – |
| Q2 2023 | $6,184 | +94.1% | 1,995 | -13.0% | 0.00% | – |
| Q1 2023 | $3,186 | -30.1% | 2,292 | 0.0% | 0.00% | – |
| Q4 2022 | $4,561 | +128.0% | 2,292 | +85.7% | 0.00% | – |
| Q3 2022 | $2,000 | -50.0% | 1,234 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 1,234 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | -92.4% | 1,234 | -91.0% | 0.00% | – |
| Q4 2021 | $66,000 | -9.6% | 13,697 | 0.0% | 0.00% | – |
| Q3 2021 | $73,000 | +4.3% | 13,697 | 0.0% | 0.00% | – |
| Q2 2021 | $70,000 | -49.3% | 13,697 | -33.4% | 0.00% | – |
| Q1 2021 | $138,000 | +56.8% | 20,553 | +6.9% | 0.00% | – |
| Q4 2020 | $88,000 | +4.8% | 19,235 | -11.7% | 0.00% | – |
| Q3 2020 | $84,000 | -78.5% | 21,784 | -80.5% | 0.00% | -100.0% |
| Q1 2020 | $390,000 | – | 111,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $102,442,000 | 9.84% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $77,176,000 | 1.36% |
| Sivik Global Healthcare LLC | 600,000 | $2,856,000 | 0.95% |
| THB ASSET MANAGEMENT | 651,150 | $3,099,000 | 0.90% |
| Eversept Partners, LP | 886,587 | $4,220,154 | 0.58% |
| Spark Investment Management LLC | 30,100 | $143,000 | 0.52% |
| GLOBEFLEX CAPITAL L P | 240,680 | $1,146,000 | 0.29% |
| Alambic Investment Management, L.P. | 19,493 | $93,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 49,901 | $238,000 | 0.13% |
| C M BIDWELL & ASSOCIATES LTD | 29,550 | $141,000 | 0.13% |